Groundbreaking stem cell therapy trial for Alzheimer’s disease underway at UTHealth Houston

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.

Shareholders approve all proposals – Biotech Investments

Galenica AG / Key word(s): AGMEGM 7th Annual General Meeting: Shareholders approve all proposals 10.04.2024 / 17:29 CET/CEST Press release The seventh Annual General Meeting

April 11, 2024

Avalo fails asthma PhII with lead candidate, shares crater

Avalo Therapeutics, a biotech working on immunology, said its lead candidate failed a Phase II study testing the treatment in a specific type of asthma

June 27, 2023

Mushrooms Inc (OTC:MSRM) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery | Psychedelic Invest

Mushrooms Inc. , ( OTC: MSRM ) a leader in mycelium research and development, proudly announces the successful filing of its non-provisional patent, titled “METHOD OF GENERATING MULTIFUNCTIONAL

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.